The University of Virginia Cancer Center is conducting a clinical research study for adults ages 18 and over, who have advanced, recurrent or metastatic endometrioid endometrial cancer. The purpose of this study is to find out if the combination of 2 immunotherapy drugs (Abemaciclib and Letrozole) is better or worse than usual approach for endometrial cancers.
Participation includes taking the study medication and attend clinic visits. Each treatment cycle is 4 weeks. The length of participation is dependent on how well you respond to the treatment.
Study-related procedures that are being done beyond your standard of care will be provided at no cost to your or your insurance.
Additional information can be found here: https://clinicaltrials.gov/ct2/show/NCT04393285